Skip to content

8-KAccepted Nov 13, 4:51 PM ET

Cerenome, Inc.: reports Q3 2026 results

CNSYCERENOME, INC.

Accepted (ET)

4:51 PM

Nov 13, 2026

Filed

Nov 13, 2026

Documents

10

Size

722.1 KB

Summary

Cerenome, Inc.: reports Q3 2026 results

Updated

What happened

  • On Nov 13, 2026, Cerenome, Inc. reported financial results for the third quarter ended Sep 30, 2026 and provided other recent corporate updates. The filing states a copy of the press release is furnished as Exhibit 99.1 to the report and is incorporated by reference.

Key details

  • Reported financial results cover the quarter ended Sep 30, 2026.
  • The press release announcing the results is furnished as Exhibit 99.1 to the Form 8-K.
  • The Form 8-K is signed by Marc H. Hedrick, M.D., President and Chief Executive Officer, dated Nov 13, 2026.

Why it may matter

  • The filing reports Item 2.02 (results of operations and financial condition), which covers the company reporting its recent financial results and related corporate updates; Exhibit 99.1 contains the press release. This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing